Delivery Order SPE2DB20D1050-SPE2DB25FH43X

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,446.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valacyclovir HCL 1 gram tablets in 90-count packages. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 22, 2024. The award was not designated under any set-aside program, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Valacyclovir HCL 1 gram tablets, a pharmaceutical product used for the treatment of viral infections. The contract has a ceiling value of $1,382.41 and an ultimate completion date of April 18, 2024. This is a firm-fixed-price contract, and there is no set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,886.52 firm fixed-price delivery order is for the supply of 90-count tablets of the antiviral drug Valacyclovir Hydrochloride 1 gram. The award has an ultimate completion date of March 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,719.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the procurement of 4,559,769,475 units of Valacyclovir HCL 1 gram tablets for military treatment facilities, veterans' healthcare programs, and other federal medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,037.07, is for the delivery of 4,556,735,302 units of Valacyclovir HCL 500 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of March 30, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
This federal contract award is for the delivery of 4,554,393,441 units of the medication Valacyclovir HCL 500 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $1,337.99 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 12, 2021 and was awarded on August 11, 2021. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $3,047.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 90-count bottles of the prescription medication Valacyclovir HCL 1 gram tablets. This contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.84 firm fixed-price delivery order is for the supply of 90-count bottles of the antiviral medication Valacyclovir HCl 1 gram tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Valacyclovir Hydrochloride, a pharmaceutical product. The contract has a ceiling value of $2,476.96 and a period of performance through July 24, 2023. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation. The contract, valued at $1,092.95, is for the delivery of the pharmaceutical product Valacyclovir Hydrochloride. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA Troop...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB25FH43X
    Delivery Order

This federal contract award, with ID SPE2DB20D1050|SPE2DB25FH43X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count bottles of the generic drug Valacyclovir Hydrochloride 1 gram tablets, with a ceiling value of $4,057.92 and a completion date of January 3, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/3/25, 11:17 AM